Investigational New Drugs,volume 30,issue 4  (08-2014)

Period of time： 2014年4期

Publisher： Springer Publishing Company

Founded in： 1983

Total resources： 32

ISSN： 0167-6997

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Investigational New Drugs,volume 30,issue 4

Menu

Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells

By Omene Coral in (2012)

Investigational New Drugs,volume 30,issue 4 , Vol. 30, Iss. 4, 2012-08 , pp. 1279-1288 (10)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis

By Cabello Christopher in (2012)

Investigational New Drugs,volume 30,issue 4 , Vol. 30, Iss. 4, 2012-08 , pp. 1289-1301 (13)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Cytotoxic effect of menadione and sodium orthovanadate in combination on human glioma cells

By Delwar Zahid in (2012)

Investigational New Drugs,volume 30,issue 4 , Vol. 30, Iss. 4, 2012-08 , pp. 1302-1310 (9)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest

By Kim Won in (2012)

Investigational New Drugs,volume 30,issue 4 , Vol. 30, Iss. 4, 2012-08 , pp. 1311-1318 (8)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models

By Di Francesco Angela in (2012)

Investigational New Drugs,volume 30,issue 4 , Vol. 30, Iss. 4, 2012-08 , pp. 1319-1330 (12)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice.

By Abolhassani Mohammad in (2012)

Investigational New Drugs,volume 30,issue 4 , Vol. 30, Iss. 4, 2012-08 , pp. 1331-1342 (12)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Cell-growth and migration inhibition of human mesothelioma cells induced by 3- O -Methylfunicone from Penicillium pinophilum and cisplatin

By Buommino Elisabetta in (2012)

Investigational New Drugs,volume 30,issue 4 , Vol. 30, Iss. 4, 2012-08 , pp. 1343-1351 (9)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks

By Kataoka Yu in (2012)

Investigational New Drugs,volume 30,issue 4 , Vol. 30, Iss. 4, 2012-08 , pp. 1352-1360 (9)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia

By Habibi Darya in (2012)

Investigational New Drugs,volume 30,issue 4 , Vol. 30, Iss. 4, 2012-08 , pp. 1361-1370 (10)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

The role of CXCR2 chemokine receptors in the oral squamous cell carcinoma

By Romanini Juliana in (2012)

Investigational New Drugs,volume 30,issue 4 , Vol. 30, Iss. 4, 2012-08 , pp. 1371-1378 (8)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Previous 1 2 3 4 5 ... 7 Next Display item(s) per page Total 64 item(s)